|
A priori filtering of post-operative (post-op) circulating tumor DNA (ctDNA) to predict recurrence in post-metastasectomy colorectal cancer patients (CRC pts) without knowledge of tumor genotype. |
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Merrimack; Roche/Genentech |
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; MedImmune; Merck; Roche |
|
|
Employment - Driver Group; Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
Travel, Accommodations, Expenses - Guardant Health |
|
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
Patents, Royalties, Other Intellectual Property - Patent pending for molecular diagnostic technology |
Travel, Accommodations, Expenses - Guardant Health |
|
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
|
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
Patents, Royalties, Other Intellectual Property - Guardant Health |
|
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
Patents, Royalties, Other Intellectual Property - One allowed patent, three patent applications for Guardant Health (Inst) |
Travel, Accommodations, Expenses - Guardant Health |
|
|
No Relationships to Disclose |
|
|
Employment - Guardant Health |
Leadership - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
Research Funding - Guardant Health |
Patents, Royalties, Other Intellectual Property - Guardant Health |
Travel, Accommodations, Expenses - Guardant Health |
|
|
Employment - Guardant Health |
Stock and Other Ownership Interests - Guardant Health |
|
|
Stock and Other Ownership Interests - MolecularMatch; Navire |
Consulting or Advisory Role - Amgen; Array BioPharma; Bayer; EMD Serono; Genentech; Guardant Health (Inst); Karyopharm Therapeutics; Merck; Roche; Symphony Evolution |
Research Funding - Amgen (Inst); Array BioPharma (Inst); Biocartis (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Guardant Health (Inst); MedImmune (Inst); Novartis (Inst); Sanofi (Inst) |